drugset / Trial / NCT07272889
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Non-randomizedSequentialOpen-labelTreatment
Summary
Drug-drug interaction study between Ethinyl Estradioll/Levonorgestrel and Bemnifosbuvir/Ruzasvir
Timeline
- Start
- 2025-12-04
- Primary completion
- 2026-02-17
- Completion
- 2026-02-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bemnifosbuvir | Other / unclassified | 550 mg | Oral |
| Subject | Levonorgestrel | Small molecule | 0.15 mg | Oral |
| Subject | Ruzasvir | Other / unclassified | 180 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 0.03 mg | Oral |
Indications
No indication recorded.